SUDEEP PHARMA
Back to Income Statement
|
SUDEEP PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹502 Cr | ₹46 Cr | ₹429 Cr | ₹3,430 Cr | ₹215 Cr |
What is the latest Revenue of SUDEEP PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹502 Cr |
| Mar2025 | ₹46 Cr |
| Mar2024 | ₹429 Cr |
| Mar2023 | ₹3,430 Cr |
| Mar2022 | ₹215 Cr |
How is Revenue of SUDEEP PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹502 Cr | 993.01 | |
| Mar2025 | ₹46 Cr | -89.29 | |
| Mar2024 | ₹429 Cr | -87.50 | |
| Mar2023 | ₹3,430 Cr | 1,494.61 | |
| Mar2022 | ₹215 Cr | - | |
Compare Revenue of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,733.7 Cr | -1.5% | 5.9% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -1.5% |
5.9% |
|
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses